Supercritical Antisolvent Versus Coevaporation— Preparation and Characterization of Solid Dispersions

REFERENCES

• Amidon G. L., Lunnernas H., Shah V. P., Crison J. R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995; 12: 413–420
   PubMed Web of Science ®Google Scholar
• Badens E., Fargeot C., Bosc N., Veesler S., Teillaud E., Charbit G. Polymorph control of drug in supercritical CO2. Proceedings of the European Conference on Drug Delivery and Pharmaceutical Technology, Sevilla, May, 10–12, 2004; 46
   Google Scholar
• Badens E., Teillaud E., Charbit G., Horváth G., Szokonya L., Bosc N., Majerik V. Solubility enhancement of a pharmaceutical ingredient using supercritical antisolvent and spray-freezing techniques. Proceedings of The 7th International Symposium on Supercritical Fluids, Orlando, May, 1–4, 2005
   Google Scholar
• Beach S., Lathan D., Sidgwick C., Hanna M., York P. Control of the physical form of Salmeterol Xinafoate. Org. Proc. Res. Dev. 1999; 3: 370–376
   Web of Science ®Google Scholar
• Bitz C., Doelker E. Influence of the preparation method on residual solvents in biodegradable microspheres. Int. J. Pharm. 1996; 131: 171–181
   Web of Science ®Google Scholar
• Bristow S., Shekunov T., Shekunov B. Yu., York P. Analysis of the supersaturation and precipitation process with supercritical CO2. J. Supercrit. Fluids 2001; 21: 257–271
   Web of Science ®Google Scholar
• Cassidy O. E., Haskayne L., Rowley G. Electrostatic charge and dissolution of surface modified phenylbutazone. Eur. J. Pharm. Sci. 1998; 6: S23
   Google Scholar
• Charbit G., Badens E., Boutin O. Methods of particle production. Supercritical Fluid Technology for Drug Product Development, Drugs and Pharmaceutical Sciences Vol. 138, P. York, U. B. Kompella, B. Y. Shekunov. Marcel Dekker, Inc, New York 2004; 159–212
   Google Scholar
• Coates J. Interpretation of Infrared Spectra, A Practical Approach. Encyclopedia of Analytical Chemistry, R. A. Meyers. John Wiley & Sons Ltd, Chichester 2000; 10815–10837
   Google Scholar
• Delneuville I., Dechesne J. P., Delattre L. Preparation and study of the characteristics of dithranol:polyvinylpyrrolidone coevaporates. Int. J. Pharm. 1998; 168: 109–118
   Google Scholar
• Fargeot C., Badens E., Charbit G., Bosc N., Teillaud E., Veesler S. Cristallisation d'un prinicipe actif: comparaison des méthodes par voie liquide et supercritique. Proceedings of The Cristal2, Toulouse, Novembre, 12–13, 2003; 55–60
   Google Scholar
• FDA. International Conference on Harmonisation, ICH Guidance on Impurities: Residual Solvents, Federal Register. 1997; 62: 67377–67388
   Google Scholar
• FDA. (2002). Draft—Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER).
   Google Scholar
• Forster A., Hempenstall J., Rades T. Investigation of drug / polymer interaction in glass solutions prepared by melt extrusion. Int. J. Vib. Spec. 2001; 5: 6, www.ijvs.com
   Google Scholar
• Jannin V., Pochard E., Chambin O. Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol® ATO 5. Int. J. Pharm. 2006; 309: 6–15
   PubMed Web of Science ®Google Scholar
• Kaczmarek H., Szalla A., Kaminska A. Study of poly(acrylic acid)-poly(vinylpyrrolidone) complexes and their photostability. Polymer 2001; 42: 6057–6069
   Web of Science ®Google Scholar
• Kim E. -J., Chun M. -K., Jang J. -S., Lee I. -H., Lee K. -R., Choi H.-K. Preparation of a solid dispersion of felodipine using a solvent wetting method. Eur. J. Pharm. Biopharm. 2006; 64: 200–205
   PubMed Web of Science ®Google Scholar
• Korsmeyer R. W., Gurny R., Doelker E. M., Buri P., Peppas N. A. Mechanism of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983; 15: 25–35
   Web of Science ®Google Scholar
• Leuner C., Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. 2000; 50: 47–60
   Web of Science ®Google Scholar
• Lochard H., Sauceau M., Freiss B. Method for the preparation of molecular complexes. World Patent WO 04096284 A1, 2004
   Google Scholar
• Majerik V., Charbit G., Badens E., Horváth G., Szokonya L., Bosc N., Teillaud E. Bioavailability enhancement of an active substance by supercritical antisolvent precipitation. J. Supercrit. Fluids 2007; 40: 101–110
   Web of Science ®Google Scholar
• Majerik V., Horváth G., Charbit G., Badens E., Szokonya L., Bosc N., Teillaud E. Novel particle engineering techniques in drug delivery: review of formulations using supercritical fluids and liquefied gases. Hung. J. Ind. Chem. 2004; 32: 41–56
   Google Scholar
• Miranda S., Yaeger S. Homing in on the best size reduction method. Chem. Eng. 1998; 105: 102–110
   Web of Science ®Google Scholar
• Pasquali I., Bettini R., Giordano F. Solid-state chemistry and particle engineering with supercritical fluids in pharmaceutics. Eur. J. Pharm. Sci. 2006; 27: 299–310
   PubMed Web of Science ®Google Scholar
• Perrut M., Jung J., Leboeuf F., Fabing I. Method for making very fine particles consisting of a principle inserted in a host molecule. World Patent WO 0232462, 2002
   Google Scholar
• Reverchon E. Supercritical antisolvent precipitation of micro- and nano-particles. J. Supercrit. Fluids 1999; 15: 1–21
   Web of Science ®Google Scholar
• Reverchon E., Della Porta G., De Rosa I., Subra P., Letourneur D. Supercritical antisolvent micronization of some biopolymers. J. Supercrit. Fluids 2000; 18: 239–245
   Web of Science ®Google Scholar
• Rogers T. L., Johnston K. P., Williams R. O., III. Solution-based particle formation of pharmaceutical powders by supercritical or compressed fluid CO2 and cryogenic spray-freezing technologies. Drug Dev. Ind. Pharm. 2001; 27: 1003–1015
   PubMed Web of Science ®Google Scholar
• Ruchatz F., Kleinebudde P., Müller B. W. Residual solvents in biodegradable microparticles. Influence of process parameters on the residual solvent in microparticles produced by the Aerosol Solvent Extraction System (ASES) process. Int. J. Pharm. Sci. 1997; 86: 101–105
   Google Scholar
• Sethia S., Squillante E. Solid dispersions: revival with greater possibilities and applications in oral drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 2003; 20: 215–247
   PubMed Web of Science ®Google Scholar
• Sethia S., Squillante E. Solid dispersions of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int. J. Pharm. 2004; 272: 1–10
   PubMed Web of Science ®Google Scholar
• Szente L., Szejtli J. Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development. Adv. Drug Delivery Rev. 1999; 36: 17–28
   PubMed Web of Science ®Google Scholar
• Van den Mooter G., Augustijns P., Blaton N., Kinget R. Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int. J. Pharm. 1998; 164: 67–80
   Web of Science ®Google Scholar
• Van Nijlen T., Brennan K., Van den Mooter G., Blaton N., Kinget R., Augustijns P. Improvement of the dissolution rate of artemisinin by means of supercritical fluid technology and solid dispersions. Int. J. Pharm. 2003; 254: 173–181
   PubMed Web of Science ®Google Scholar
• Yong C. S., Lee M.-K., Park Y.-J., Kong K.-H., Xuan J. J., Kim J.-H., Kim J.-A., Lyoo W. S., Han S. S., Rhee J.-D., Kim J. O., Yang C. H., Kim C.-K., Choi H.-G. Enhanced oral bioavailability of ibuprofen in rats by poloxamer gel using poloxamer 188 and menthol. Drug. Dev. Ind. Pharm. 2005; 31: 615–622
   PubMed Web of Science ®Google Scholar